Epstein Secrets

From: Martin Nowak To: Jeffrey Epstein <[email protected]> Subject: Fwd: some info and papers Date: Sat, 07 Aug 2010 13:16:17 +0000 Attachments: Science06.pdf; Nature10.pdf; Nature0

From: Martin Nowak To: Jeffrey Epstein <[email protected]> Subject: Fwd: some info

From: Martin Nowak To: Jeffrey Epstein <[email protected]> Subject: Fwd: so

I am also working on evolutionary processes in medicine such as the dynamics of virus infections and cancer. I have an excellent collaboration with Bert Vogelstein, who is one of the leading cancer biologists in the world. Many years ago my calculations helped to obtain a quantitative understanding of HIV infe

ergence of aggressive cells. "It's becoming clear to the medical establishment that a cocktail of inhibitor drugs need to be given simultaneously," Jeffrey Epstein remarked, founder of the Program for Evolutionary Dynamics at Harvard University. The department or PED, studies the evolution of microbiology with

drugs need to be given simultaneously," Jeffrey Epstein remarked, founder of the Program for Evolutionary

nhibitor drugs need to be given simultaneously," Jeffrey Epstein remarked, founder of the Program for Evol

FR TK inhibitors became resistant from a single mutation of the protein T790M within the EGFR kinase domain. PED's work caught the attention of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Financier, Jeffrey Epstein, Accelerates the Course of Evolution at Harvard Evolution is always on the move but nowhere has it been more in flux than at Harvard University. In

e Advanced Institute for Studies at Princeton, met with an unknown New York financier called Jeffrey Epstein, to discuss the evolution of language. Epstein was by then an established philanthropist in the sciences. But what emerged was far more pragmatic than the first evolutionary theory of irregular

Financier, Jeffrey Epstein, Accelerates the Course of Evolution at H

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

A Financier Called Jeffrey Epstein Accelerates the Course of Evolution at Harvard Evolution is always on the move but nowhere has it been more in flux than at Harvard University. Ind

into the evolution and treatment of major diseases from cancer to infectious bacteria and viruses such as HIV. It all began in March of 2000 when Epstein, a New York fund manager with a passion for cutting- edge science, invited Nowak to organize a conference on the evolution of language. Nowak was th

A Financier Called Jeffrey Epstein Accelerates the Course of Evolution at Ha

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

From: Lesley Groff Sent: Thursday, May 31, 2012 1:36 PM To: Jeffrey Epstein CC Subject: Fwd: 1st write-up Attachments: Martin Nowak summary.docx; Untitled attachment 00129.htm Begin forwarded message: From: Lindsay Borthwi

From: Lindsay Borthwick Date: May 31, 2012 9:33:58 AM EDT To: Lesley Groff Subject: 1st =rite-up Hi Lesley, Please find =ttached a write-up for Jeffrey. Also, I want to pass along the note =elow. Many thanks! Lindsay Hi Jeffrey, I =ope this write-up is to your liking. It's about Martin's work. I

nt: Thursday, May 31, 2012 1:36 PM To: Jeffrey Epstein CC Subject: Fwd: 1st write-up Attachments: Ma

nce itself. This piece focuses on his work on =usociality in ants and prelife. (I could easily write a short follow-up =iece on his cancer work with Bert Vogelstein, particularly once their =orthcoming paper is published in Nature.) All this to say that ='m not married to this format. What I've written is long a

From: Lesley Groff Sent: Sunday, June 10, 2012 12:31 PM To: Epstein Jeffrey Subject: Fwd: 1st write-up-Lindsay Borthwick Attachments: Martin Nowak summary.docx; Untitled attachment 00484.htm Sent from my iPhone ar>Begin

Groff Subject: 1st write-up Hi Lesley,</=pan> Please find attached a write-up for Jeffrey.=Also, I want to pass along the note below. Lindsay Hi Jeffrey, I hope this write-u= is to your liking. It's about Martin's work. I usually have a strong sense=of format when I start writing a piece because I k

roff Sent: Sunday, June 10, 2012 12:31 PM To: Epstein Jeffrey Subject: Fwd: 1st write-up-Lindsay Bort

nce itself. This piece focuses o= his work on eusociality in ants and prelife. (I could easily write a short=follow-up piece on his cancer work with Bert Vogelstein, particularly once t=eir forthcoming paper is published in Nature.) <=pan>AII this to say that I'm not married to this format. What I've written i=

mutation analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer research

n analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer research

mutation analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer r

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi

mutation analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer research

n analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer research

mutation analysis," out, whose foundation, the Jeffrey Epstein VI Foundation. hinds mining edge cancer r

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi

! I will pass along. Thank you Lindsay On May 31, 2012, at 9:33 AM, Lindsay Borthwick wrote: > Hi Lesley, > • Please find attached a write-up for Jeffrey. Also, I want to pass along the note below. > • Many thanks! > • Lindsay > • Hi Jeffrey, > • I hope this write-up is to your liking. It's abo

nce itself. This piece focuses on his work on eusociality in ants and prelife. (I could easily write a short follow-up piece on his cancer work with Bert Vogelstein, particularly once their forthcoming paper is published in Nature.) > All this to say that I'm not married to this format. What I've written is lon